Estimated reading time: 4 minutes

Six-year-old Louis McGill is exactly the kind of kid who fills a room without trying. He sings, he dances, he makes friends wherever he goes. He loves baseball, swimming and playing outside with his little brother, Presley.

“He’s a big entertainer,” his mom, Laura, said. “He just loves people.”

That joy has been a constant in Louis’ life through his earliest days, and through a cancer journey that would test any family.

Louis was born after what Laura describes as a smooth, joyful pregnancy. A few hours after his birth, he was diagnosed with Down syndrome. Soon after, he was transferred to Norton Children’s Hospital neonatal intensive care unit (NICU) due to oxygen needs and a minor heart issue common in children with Down syndrome.

“It was scary at first, just being separated from him,” Laura said. “But once we got there, we knew we were in the best place we could be.”

Louis spent about a week in the NICU before going home. Over the next several years, he thrived — attending preschool, building friendships and developing his vibrant personality. Aside from routine monitoring and a few minor procedures, his health remained strong.

That changed in early 2025.

A challenging diagnosis

Children with Down syndrome are more prone to certain types of cancer, particularly leukemia.

In January 2025, shortly after winter break, Louis began showing unusual symptoms, including a stiff neck, fatigue and gradual loss of mobility. What initially seemed like a minor injury or infection worsened over several weeks.

“We kept hoping it was something simple,” Laura said. “But in the back of our minds, we knew.”

After many doctor visits and declining blood counts, Louis was sent to Norton Children’s Hospital for further testing. Following an MRI and bone marrow biopsy, doctors confirmed the diagnosis: B-cell acute lymphoblastic leukemia (ALL).

“You feel like you’re in a fog,” Laura said. “But the moment the doctors left the room, we looked at each other and said, ‘We’re on this journey for a reason.’”

Treatment and resilience

Louis immediately began treatment through Norton Children’s Cancer Institute. While many children respond to standard therapy, his care team adjusted his plan when he wasn’t fully in remission after the initial phase, moving him to a treatment tailored specifically for children with Down syndrome and leukemia.

That personalized approach made a difference. By June 2025, Louis was in remission.

Treatment, however, didn’t end there. Like many children with ALL, he continues therapy to prevent relapse, with maintenance expected through June 2027. His care has included chemotherapy, immunotherapy and a feeding tube placed to help manage nutrition and medications.

Through it all, Louis has remained remarkably resilient.

“He takes it one moment at a time,” Laura said. “He might be upset one minute and the next he’s smiling again.”

Looking ahead

Today, Louis is back in school, preparing for first grade and returning to activities he loves, including the Miracle League baseball program he had to pause during treatment.

“He’s just happy,” Laura said. “He loves life.”

While the family has not yet marked the traditional end-of-chemo milestone of ringing the bell, they’re looking forward to that day. It will come when Louis full course of therapy is complete.

“It’s going to be a big celebration,” Laura said.

Until then, they are focused on what Louis does best: living fully in the moment.

“We hope he just keeps being himself,” she said. “Healthy, happy and bringing joy to others.”

And for the Norton Children’s team who has walked beside them since the beginning, Laura’s gratitude is simple.

“The level of care is incredible,” she said. “Not just medically, but how they care for the whole family. They were meant to do this, and we are so grateful they are always there for us.”

Photo Courtesy of Mackenzie Edwards of Mackenzie Edwards Photography